24
Participants
Start Date
October 6, 2009
Primary Completion Date
August 23, 2011
Study Completion Date
August 23, 2011
CS-1008
CS-1008 intravenous (IV) infusion 10 mg/kg on Day 1 of Cycle 1 and 8 mg/kg once every 3 weeks (1 cycle) for Cycle 2-6
Paclitaxel
Paclitaxel 175 mg/m\^2 IV infusion once every 3 weeks (1 cycle) for 6 cycles
Carboplatin
Carboplatin (target area under the concentration versus time curve of 6.0 mg/mL/min using the Calvert Formula) IV infusion once every 3 weeks (1 cycle) for 6 cycles
Univ. Alabama, Birmingham
Barnes Jewish Hospital, St Louis
University of Oklahoma, Oklahoma City
Lead Sponsor
Daiichi Sankyo
INDUSTRY